Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

  • There is currently no data for TM17

Director Share Purchase

23 Apr 2020 15:07

RNS Number : 6993K
Team17 Group PLC
23 April 2020
 

23 April 2020

Team17 Group plc

("Team17", the "Group" or the "Company")

 

Director Share Purchase

Team17, a global games entertainment label, creative partner and developer of independent ("indie") premium video games, has been notified that on 23 April 2020, Mark Crawford, Chief Financial Officer, purchased a total of 5,357 Ordinary Shares at a price of 560 pence per share. Following this purchase, Mr Crawford holds 5,357 Ordinary Shares, representing 0.004% of the current issued share capital of the Company.

The Group's current share capital consists of 131,402,276 Ordinary Shares with voting rights.

1

Details of the person discharging managerial responsibilities / person closely associated

a) 

Name

Mr. Mark Crawford

2

Reason for the notification

a)

Position/status

Chief Financial Officer / PDMR

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Team17 Group plc

b)

LEI

2138006EUUCCL4ZI5E51

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of GBP0.01

 

 

GB00BYVX2X20

 

b)

Nature of the transaction

Direct purchase of shares

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

£5.60

5,357

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

23 April 2020

f)

Place of the transaction

London Stock Exchange

 

 

Enquiries:

 

Team17 Group plc

Debbie Bestwick MBE, Chief Executive Officer

Mark Crawford, Chief Financial Officer

 

via Vigo Communications

+44 (0)20 7390 0238

GCA Altium (Nominated Adviser)

Phil Adams / Adrian Reed / Paul Lines

 

+44 (0)845 505 4343

Berenberg (Broker)

Chris Bowman / Marie Moy / Alix Mecklenburg-Solodkoff

 

+44 (0)20 3207 7800

Vigo Communications (Financial Public Relations)

Jeremy Garcia / Charlie Neish

team17@vigocomms.com

+44 (0)20 7390 0233

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEALLDAESEEFA
Date   Source Headline
19th Sep 20237:00 amRNSHalf Year Results
12th Sep 20239:00 amRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSBoard Update
17th Aug 20234:46 pmRNSHolding(s) in Company
14th Aug 20239:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSNotice of Results & Trading Update
19th Jul 20237:00 amRNSDirectorate Changes
18th Jul 20232:15 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSAppointment of Joint Corporate Broker
12th Jul 20233:36 pmRNSDirector/PDMR Shareholding
22nd Jun 20232:01 pmRNSResult of AGM
16th Jun 20234:27 pmRNSHolding(s) in Company
14th Jun 20238:55 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAppointment of Group Chief Executive Officer
26th May 20237:01 amRNSBoard Update
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th May 20234:42 pmRNSHolding(s) in Company
15th May 202312:50 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTeam17's astragon Acquires Independent Arts
13th Apr 20233:40 pmRNSIssue of Shares
12th Apr 20238:20 amRNSDirector/PDMR Shareholding
31st Mar 202311:15 amRNSDirector/PDMR Shareholding
28th Mar 20237:01 amRNSDirector Update
28th Mar 20237:00 amRNSUnaudited Final Results 2022
13th Mar 20234:49 pmRNSDirector/PDMR Shareholding
13th Mar 20239:05 amRNSNo Material Exposure to Silicon Valley Bank
2nd Mar 20237:00 amRNSNotice of Results & Analyst/Investor Presentations
13th Feb 20231:41 pmRNSDirector/PDMR Shareholding
31st Jan 20232:40 pmRNSHoldings in Company
19th Jan 20235:20 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSTrading Update
12th Jan 20239:04 amRNSDirector/PDMR Shareholding
10th Jan 20236:19 pmRNSHolding(s) in Company
9th Jan 20232:48 pmRNSTrading Update
13th Dec 20223:51 pmRNSDirector/PDMR Shareholding
17th Nov 20228:46 amRNSHolding(s) in Company
11th Nov 20225:13 pmRNSDirector/PDMR Shareholding
20th Oct 202212:11 pmRNSHolding(s) in Company
18th Oct 20221:42 pmRNSDirector/PDMR Shareholding
13th Sep 20224:32 pmRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSHalf Year Results
5th Sep 20227:00 amRNSNotice of Results & Analyst/Investor presentations
12th Aug 20221:29 pmRNSDirector/PDMR Shareholding
18th Jul 20225:08 pmRNSHolding(s) in Company
15th Jul 20223:25 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
12th Jul 20223:56 pmRNSDirector/PDMR Shareholding
30th Jun 20223:58 pmRNSGrant of Options to Directors / PDMRs
29th Jun 20224:39 pmRNSResult of AGM
15th Jun 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.